User login
Adherence to Heparin: The Type Makes a Difference
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Adherence to Heparin: The Type Makes a Difference
Article PDF
Issue
Federal Practitioner - 27(9)
Publications
Page Number
42
Legacy Keywords
thromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolismthromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolism
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(9)
Issue
Federal Practitioner - 27(9)
Page Number
42
Page Number
42
Publications
Publications
Article Type
Display Headline
Adherence to Heparin: The Type Makes a Difference
Display Headline
Adherence to Heparin: The Type Makes a Difference
Legacy Keywords
thromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolismthromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolism
Legacy Keywords
thromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolismthromboprophylaxis, injection-based, low-molecular-weight heparin, unfractionated heparin, heparin, anticoagulant agent, oral dosing, venous thromboembolism
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Celecoxib Gets Another Look
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Celecoxib Gets Another Look
Article PDF
Issue
Federal Practitioner - 27(9)
Publications
Page Number
E2
Legacy Keywords
celecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDORcelecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDOR
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(9)
Issue
Federal Practitioner - 27(9)
Page Number
E2
Page Number
E2
Publications
Publications
Article Type
Display Headline
Celecoxib Gets Another Look
Display Headline
Celecoxib Gets Another Look
Legacy Keywords
celecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDORcelecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDOR
Legacy Keywords
celecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDORcelecoxib, omeprazole, diclofenac, osteoarthritis, rheumatoid arthritis, gastrointestinal, cyclo-oxygenase-2-selective, non-steroidal anti-inflammatory drug, NSAID, proton-pump inhibitor, CONDOR
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Capsaicin Patch Effective and Safe Over the Long Term?
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Capsaicin Patch Effective and Safe Over the Long Term?
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Topics
Page Number
28
Legacy Keywords
capsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interactioncapsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interaction
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
28
Page Number
28
Publications
Publications
Topics
Article Type
Display Headline
Capsaicin Patch Effective and Safe Over the Long Term?
Display Headline
Capsaicin Patch Effective and Safe Over the Long Term?
Legacy Keywords
capsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interactioncapsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interaction
Legacy Keywords
capsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interactioncapsaicin patch, postherpetic neuralgia, PHN, HIV-associated distal sensory polyneuropathy, HIV-DSP, peripheral neuropathic pain syndrome, pain management, drug interaction
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Medication Reconciliation: Still Some Gaps to Fill
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Medication Reconciliation: Still Some Gaps to Fill
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Page Number
27
Legacy Keywords
at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
27
Page Number
27
Publications
Publications
Article Type
Display Headline
Medication Reconciliation: Still Some Gaps to Fill
Display Headline
Medication Reconciliation: Still Some Gaps to Fill
Legacy Keywords
at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug
Legacy Keywords
at-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drugat-home medication, patient safety, medication reconciliation, discrepancy, adverse drug event, ADE, cardiovascular drug
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Fracture Risk with Proton Pump Inhibitors
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Fracture Risk with Proton Pump Inhibitors
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Page Number
27
Legacy Keywords
proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
27
Page Number
27
Publications
Publications
Article Type
Display Headline
Fracture Risk with Proton Pump Inhibitors
Display Headline
Fracture Risk with Proton Pump Inhibitors
Legacy Keywords
proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA
Legacy Keywords
proton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDAproton pump inhibitors, PPI, heartburn, fracture, epidemiologic study, esomeprazole, dexlansoprazole, omeprazole, lansoprazole, FDA
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Liver Injury Warning for Orlistat
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Liver Injury Warning for Orlistat
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Page Number
27
Legacy Keywords
weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
27
Page Number
27
Publications
Publications
Article Type
Display Headline
Liver Injury Warning for Orlistat
Display Headline
Liver Injury Warning for Orlistat
Legacy Keywords
weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline
Legacy Keywords
weight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKlineweight loss, orlistat, Alli, Xenical, liver damage, FDA, liver injury, Genentech, GlaxoSmithKline
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Opinions About Medications Change Over Time
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Opinions About Medications Change Over Time
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Topics
Page Number
26
Legacy Keywords
nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
26
Page Number
26
Publications
Publications
Topics
Article Type
Display Headline
Opinions About Medications Change Over Time
Display Headline
Opinions About Medications Change Over Time
Legacy Keywords
nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance
Legacy Keywords
nonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherancenonadherance, chronic ischemic heart disease, Beliefs about Medicines Questionnaire-Specific, BMQ-Specific, Medication Applied and Stustained Over Time, MAINTAIN, heart medication, adherance
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Treatment May be Effective for Mild Stroke
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Treatment May be Effective for Mild Stroke
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Topics
Page Number
26
Legacy Keywords
mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
26
Page Number
26
Publications
Publications
Topics
Article Type
Display Headline
Treatment May be Effective for Mild Stroke
Display Headline
Treatment May be Effective for Mild Stroke
Legacy Keywords
mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage
Legacy Keywords
mild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhagemild stroke, acute ischemic stroke, IV thrombolysis, intravenous tissue plasminogen activator, t-PA, National Institutes of Health Stroke Scale, NIHSS, modified Rankin scale, mRS, symptomatic hemorrhage
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Cooling the Burning Mouth
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Cooling the Burning Mouth
Article PDF
Issue
Federal Practitioner - 27(8)
Publications
Page Number
E3
Legacy Keywords
burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(8)
Issue
Federal Practitioner - 27(8)
Page Number
E3
Page Number
E3
Publications
Publications
Article Type
Display Headline
Cooling the Burning Mouth
Display Headline
Cooling the Burning Mouth
Legacy Keywords
burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid
Legacy Keywords
burning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroidburning mouth syndrome, BMS, oral symptoms, dry mouth, impaired taste, menopause, parafunctional habit, topical lubricant, corticosteroid
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Racial Differences in Androgen-Deprivation Therapy
Article Type
Changed
Thu, 12/15/2022 - 15:11
Display Headline
Racial Differences in Androgen-Deprivation Therapy
Article PDF
Issue
Federal Practitioner - 27(7)
Topics
Page Number
29
Legacy Keywords
african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(7)
Issue
Federal Practitioner - 27(7)
Page Number
29
Page Number
29
Topics
Article Type
Display Headline
Racial Differences in Androgen-Deprivation Therapy
Display Headline
Racial Differences in Androgen-Deprivation Therapy
Legacy Keywords
african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology
Legacy Keywords
african american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urologyafrican american, metastatic prostate cancer, androgen deprivation therapy, ADT, orchiectomy, luteinizing hormone-releasing hormone antagonists, Cancer, Endocrinology, Urology
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document